References: 1. Neuroendocrine Tumor Research Foundation. Managing Symptoms of Neuroendocrine Tumors. Available at:
https://netrf.org/for-patients/living-with-nets/symptom-management/. Accessed: October 2021.
2. Neuroendocrine Tumor Research Foundation. Eating Right with Neuroendocrine Tumors. Available at:
https://netrf.org/for-patients/living-with-nets/nutrition/. Accessed: October 2021.
3. Cancer Treatment Centers of America. Nutritional Support. Available at:
https://www.cancercenter.com/integrative-care/nutritional-support. Accessed: October 2021.
4. Neuroendocrine Cancer UK. The NPF Handbook. Available at:
https://www.neuroendocrinecancer.org.uk/wp-content/uploads/2020/03/NET-Patient-Foundation-Handbook.pdf. Accessed: October 2021.
5. Middle East Neuroendocrine Tumor Society. Nutrition and Neuroendocrine Cancer Int Ed 2021. Available at:
https://menets.org/nen-nutrition-books. Accessed: October 2021.
6. Neuroendocrine Cancer UK. Diet & Nutrition. Available at:
https://www.neuroendocrinecancer.org.uk/neuroendocrine-cancer/diet-nutrition/. Accessed: October 2021.
7. Macmillan Cancer Support. Managing the Symptoms of Cancer. Available at:
https://cdn.macmillan.org.uk/dfsmedia/1a6f23537f7f4519bb0cf14c45b2a629/790-source/mac11671-managing-symptoms-of-cancer-e10-pdf. Accessed: October 2021.
8. Neuroendocrine Tumor Research Foundation. Exercise while Living with a Neuroendocrine Tumor. Available at:
https://netrf.org/for-patients/living-with-nets/exercise/. Accessed: October 2021.
9. Cancer Research UK. Exercise guidelines for cancer patients. Available at:
https://www.cancerresearchuk.org/about-cancer/coping/physically/exercise-guidelines. Accessed: October 2021.
10. Cancer Research UK. Coping physically. Available at:
https://www.cancerresearchuk.org/about-cancer/coping/physically. Accessed: October 2021.
11. Macmillan. How to tell people you have cancer. Available at:
https://www.macmillan.org.uk/cancer-information-and-support/diagnosis/talking-about-cancer/how-to-tell-people-you-have-cancer. Accessed: October 2021.
12. Cancer Research UK. Trying to stay positive. Available at:
https://www.cancerresearchuk.org/about-cancer/coping/emotionally/cancer-and-your-emotions/trying-to-stay-positive. Accessed: October 2021.
13. Cancer Research UK. Art therapy. Available at:
https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/complementary-alternative-therapies/individual-therapies/art-therapy. Accessed: October 2021.
14. Cancer Research UK. Managing your emotions. Available at:
https://www.cancerresearchuk.org/about-cancer/coping/emotionally/cancer-and-your-emotions/managing-your-emotions. Accessed: October 2021.
15. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009; 45(2): 228–247.
16. de Mestier L, Dromain C, d’Assignies G et al. Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art. Endocr Relat Cancer. 2014; 21(3): R105–R120.
17. Fazio N. Watch and wait policy in advanced neuroendocrine tumors: What does it mean? World J Clin Oncol 2017; 8(2): 96-99.
18. Pavel M, Öberg K, Falconi M et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7): 844–860.
19. Merino-Casabiel X, Aller J, Arbizu J, et al. Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors. Clin Transl Oncol. 2018; 20(12): 1522–1528.
20. Sansone A, Lauretta R, Vottari S, et al. Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors. Cancers (Basel). 2019; 11(8): 1113.
21. Caplin M, Sundin A, Nillson O, et al. ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms. Neuroendocrinology. 2012; 95(2): 88–97.
22. Niederle B, Pape U-F, Costa F, et al. ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum. Neuroendocrinology. 2016; 103(2): 125–138.
23. Strosberg J, Wolin E, Chasen B et al. Health-Related Quality of Life in Patients with Progressive Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate in the Phase III NETTER-1 trial. J Clin Oncol. 2018; 36(25): 2578–2584.
24. Kos-Kudła B, Ćwikła J, Ruchała M et al. Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide. Contempt Oncol (Pozn) 2017; 21(2): 115–122.
25. Cancer.Net. Neuroendocrine tumors: Types of treatment. Available at:
https://www.cancer.net/cancer-types/neuroendocrine-tumors/types-treatment. Accessed: October 2021.